Epidemiology of ACHD

What Has Changed and What is Changing?

Abigail Khan, Michelle Gurvitz

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

The worldwide population of adults with congenital heart disease (ACHD) has grown steadily over the last few decades, estimated at approximately 1.4 million people in 2010 (Gilboa et al., 2016). Innovations in surgical and medical treatment of children with congenital heart disease (CCHD) have dramatically improved survival, resulting in a growing population of ACHD patients with unique health needs (Marelli et al., 2014; Khairy et al., 2010). This growth has significant implications for health care providers and health systems, which must adapt to meet the demands of caring for this complex population. Obtaining an accurate estimate of the population prevalence of ACHD is essential to define the population and to better advocate for resources to meet the needs of this group. While there is a general consensus that the prevalence of CCHD at birth is about 8 per 1000 live births, defining the prevalence in the adult population is a more challenging endeavor (van der Linde et al., 2011).

Original languageEnglish (US)
Pages (from-to)275-281
Number of pages7
JournalProgress in Cardiovascular Diseases
Volume61
Issue number3-4
DOIs
StatePublished - Sep 1 2018

Fingerprint

Heart Diseases
Epidemiology
Population
Health
Live Birth
Health Personnel
Consensus
Parturition
Survival
Growth
Therapeutics

Keywords

  • Adult congenital heart disease
  • Epidemiology
  • Surveillance

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Epidemiology of ACHD : What Has Changed and What is Changing? / Khan, Abigail; Gurvitz, Michelle.

In: Progress in Cardiovascular Diseases, Vol. 61, No. 3-4, 01.09.2018, p. 275-281.

Research output: Contribution to journalReview article

@article{da5add3ca1454192b85327e07cfe34cb,
title = "Epidemiology of ACHD: What Has Changed and What is Changing?",
abstract = "The worldwide population of adults with congenital heart disease (ACHD) has grown steadily over the last few decades, estimated at approximately 1.4 million people in 2010 (Gilboa et al., 2016). Innovations in surgical and medical treatment of children with congenital heart disease (CCHD) have dramatically improved survival, resulting in a growing population of ACHD patients with unique health needs (Marelli et al., 2014; Khairy et al., 2010). This growth has significant implications for health care providers and health systems, which must adapt to meet the demands of caring for this complex population. Obtaining an accurate estimate of the population prevalence of ACHD is essential to define the population and to better advocate for resources to meet the needs of this group. While there is a general consensus that the prevalence of CCHD at birth is about 8 per 1000 live births, defining the prevalence in the adult population is a more challenging endeavor (van der Linde et al., 2011).",
keywords = "Adult congenital heart disease, Epidemiology, Surveillance",
author = "Abigail Khan and Michelle Gurvitz",
year = "2018",
month = "9",
day = "1",
doi = "10.1016/j.pcad.2018.08.004",
language = "English (US)",
volume = "61",
pages = "275--281",
journal = "Progress in Cardiovascular Diseases",
issn = "0033-0620",
publisher = "W.B. Saunders Ltd",
number = "3-4",

}

TY - JOUR

T1 - Epidemiology of ACHD

T2 - What Has Changed and What is Changing?

AU - Khan, Abigail

AU - Gurvitz, Michelle

PY - 2018/9/1

Y1 - 2018/9/1

N2 - The worldwide population of adults with congenital heart disease (ACHD) has grown steadily over the last few decades, estimated at approximately 1.4 million people in 2010 (Gilboa et al., 2016). Innovations in surgical and medical treatment of children with congenital heart disease (CCHD) have dramatically improved survival, resulting in a growing population of ACHD patients with unique health needs (Marelli et al., 2014; Khairy et al., 2010). This growth has significant implications for health care providers and health systems, which must adapt to meet the demands of caring for this complex population. Obtaining an accurate estimate of the population prevalence of ACHD is essential to define the population and to better advocate for resources to meet the needs of this group. While there is a general consensus that the prevalence of CCHD at birth is about 8 per 1000 live births, defining the prevalence in the adult population is a more challenging endeavor (van der Linde et al., 2011).

AB - The worldwide population of adults with congenital heart disease (ACHD) has grown steadily over the last few decades, estimated at approximately 1.4 million people in 2010 (Gilboa et al., 2016). Innovations in surgical and medical treatment of children with congenital heart disease (CCHD) have dramatically improved survival, resulting in a growing population of ACHD patients with unique health needs (Marelli et al., 2014; Khairy et al., 2010). This growth has significant implications for health care providers and health systems, which must adapt to meet the demands of caring for this complex population. Obtaining an accurate estimate of the population prevalence of ACHD is essential to define the population and to better advocate for resources to meet the needs of this group. While there is a general consensus that the prevalence of CCHD at birth is about 8 per 1000 live births, defining the prevalence in the adult population is a more challenging endeavor (van der Linde et al., 2011).

KW - Adult congenital heart disease

KW - Epidemiology

KW - Surveillance

UR - http://www.scopus.com/inward/record.url?scp=85053119280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053119280&partnerID=8YFLogxK

U2 - 10.1016/j.pcad.2018.08.004

DO - 10.1016/j.pcad.2018.08.004

M3 - Review article

VL - 61

SP - 275

EP - 281

JO - Progress in Cardiovascular Diseases

JF - Progress in Cardiovascular Diseases

SN - 0033-0620

IS - 3-4

ER -